Aptinyx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Aptinyx and buy or sell other stocks, options, and ETFs commission-free!

About APTX

Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. 

CEO
Craig R. Jalbert
CEOCraig R. Jalbert
Employees
12
Employees12
Headquarters
Evanston, Illinois
HeadquartersEvanston, Illinois
Founded
2015
Founded2015
Employees
12
Employees12

APTX Key Statistics

Market cap
6.50M
Market cap6.50M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
Dividend yield
Average volume
536.11K
Average volume536.11K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.72
52 Week high$0.72
52 Week low
$0.009
52 Week low$0.009
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.